| __timestamp | ADMA Biologics, Inc. | Agios Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 100371000 |
| Thursday, January 1, 2015 | 7015946 | 141827000 |
| Friday, January 1, 2016 | 7688238 | 220163000 |
| Sunday, January 1, 2017 | 6229587 | 292681000 |
| Monday, January 1, 2018 | 3926120 | 341324000 |
| Tuesday, January 1, 2019 | 2343848 | 410894000 |
| Wednesday, January 1, 2020 | 5907013 | 367470000 |
| Friday, January 1, 2021 | 3646060 | 256973000 |
| Saturday, January 1, 2022 | 3613764 | 279910000 |
| Sunday, January 1, 2023 | 3300000 | 288903000 |
| Monday, January 1, 2024 | 301286000 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, ADMA Biologics, Inc. and Agios Pharmaceuticals, Inc. have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Agios Pharmaceuticals consistently outpaced ADMA Biologics in R&D spending, with an average annual expenditure nearly 50 times greater. Agios's peak investment in 2019 reached approximately $411 million, underscoring its aggressive pursuit of groundbreaking therapies. In contrast, ADMA Biologics's R&D spending peaked in 2014 at around $9.5 million, reflecting a more conservative strategy.
Despite these differences, both companies have shown a commitment to advancing medical science, albeit at different scales. This data highlights the diverse strategies within the biotech sector, where both high and low R&D investments can lead to significant breakthroughs.
Comparing Innovation Spending: Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
Comparing Innovation Spending: Bio-Techne Corporation and Agios Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.
PTC Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Vericel Corporation and Agios Pharmaceuticals, Inc.
R&D Insights: How Arrowhead Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Agios Pharmaceuticals, Inc. vs Iovance Biotherapeutics, Inc.